Marlboro maker Altria said on Thursday its annual adjusted profit could be lower than estimated, citing rising competition ...

Altria said it may not be able to meet its 2028 business projections for the category due to a “challenging” operating ...

New regulations, a patent battle, and an illicit vape crisis threaten Altria's future--will its legendary dividends hold up?

Altria , the maker of Marlboro cigarettes, has placed under review its 2028 goals for selling alternatives to smoking on the ...

Yet Altria still leads the cigarette market by a wide margin, its profits are solid, and its dividend that yields 8% annually ...

The main reason Altria stock pulled back was its guidance came up short. Management said adjusted earnings per share would grow 2% to 5%, reaching $5.22 to $5.37, which compares to the analyst ...

Altria Group stock dipped in Thursday morning trading after the maker of Marlboro cigarettes reported fourth-quarter and full-year earnings that matched analysts’ estimates. Shares of Altria Group ...

Everyone seems to agree candy-flavored vapes are bad for kids. So why can’t lawmakers find a way to block their sale?

The U.S. International Trade Commission ruled that the Altria-owned company’s vaping devices violate four of Juul’s patents.

Altria Group, Inc.'s Q4 earnings are expected to meet or exceed consensus, driven by strong pricing power and operational efficiencies offsetting cigarette volume declines. Looking to 2025, Altria ...

This is compounded by limited enforcement against illicit vape products and the introduction of IQOS by Philip Morris International in the US market, which could further erode Altria’s market share.